An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
The total investment is in the region of Rs 200 crore
The association has lined up a string of prominent speakers from the government and private sector. Seasoned veterans and industry bigwigs will grace the two-day event in Mumbai
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant
An intuitive monitor featuring a patient-tailored approach is now in clinical use in select centres in U.S. and Europe
The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC
Subscribe To Our Newsletter & Stay Updated
